Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer
Phase 2
- Conditions
- advanced nonsquamous, non-small cell lung cancer
- Registration Number
- JPRN-UMIN000019049
- Lead Sponsor
- Meiwa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
judged inappropriate by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method